Abstract
Objective
To analyze the frequency of performing bimanual palpation (BP) during transurethral resection of the bladder tumor (TURBT) and to identify its predictors.
Material and methods
This retrospective analysis enrolled 568 consecutive patients, who underwent TURBT due to primary bladder cancer. There were thirty surgeons involved in the analysis, each performed a mean of 18.9 TURBTs (range 1–43). Univariate and multivariate logistic regression analyses were performed to identify factors predicting the BP use.
Results
Two hundred and sixty-five patients (46.7%) underwent BP. BP was performed in 36.1% of Ta tumors, 49.1% of T1 tumors and 76.6% of ≥T2 tumors (p<0.001); in 60.2% of tumors >3 cm and in 33.3% of tumors <3 cm (p<0.001). Female, and male doctors performed BP in 38.3%, and 48.8% of the cases, respectively (p=0.01). Senior residents performed BP more often than junior residents and certified junior and senior urologists (64.6% vs. 39.2% vs. 48.2% vs. 31.1%, respectively; p=0.03). In multivariate logistic regression analysis higher tumor stage, larger tumor size, as well as senior residents and male surgeons performing TURBT were independent predictors of BP.
Conclusion
Though BP is recommended for each patient at the time of TURBT, it is performed only in the minority of patients undergoing TURBT, mainly those with advanced or larger tumors, operated by senior residents and male surgeons.
Keywords: Bladder cancer, cancer staging, patterns of care, physical examination
Introduction
Bladder cancer is the most common urinary tract malignancy, affecting 430,000 people yearly all over the world.[1] At the time of the diagnosis, about 78% of the patients have non-muscle-invasive bladder cancer (NMIBC), while a muscle-invasive bladder cancer (MIBC) is diagnosed in the remaining percentage of patients.[2] Accurate staging before treatment is essential for appropriate patient management. Standard staging methods comprise bimanual palpation (BP) at the time of transurethral resection of the bladder tumor (TURBT), microscopic examination of TURBT surgical specimen and use of computed tomography (CT) or magnetic resonance imaging (MRI).[3–6] BP is an old and traditional clinical staging tool with limited and inconsistent evidence concerning its diagnostic accuracy. According to clinical guidelines released by the European Association of Urology (EAU), BP remains a standard part of TURBT protocol.[7] However, clinical observations suggest that-in the era of imaging studies-surgeons often do not perform BP. However, this phenomenon has not been accurately studied yet.
The aim of the study was to analyze the frequency of performing BP during TURBT and to identify its predictors.
Material and methods
Patients
Medical records of 568 consecutive patients who underwent TURBT in a single department in the period of January 2011–December 2016 due to primary bladder cancer were reviewed retrospectively. Demographic (sex and age), surgical (number, size and location of tumors) and pathological (stage and grade) parametres were analyzed. Tumors were staged according to the 2009 TNM classification and graded according to the 2004 WHO/ISUP grading system. BP was defined as the palpation of the bladder with left hand placed on the lower abdominal wall and right index finger introduced into a vagina in the female or the rectum in the male patients. BPs were performed in the operative room directly before TURBT, when patients were already anesthetized. Patients were considered to undergo BP based on their surgical reports.
Surgeons
Six female and 24 male surgeons who individually performed the avarage number of 18.9 (range 1–43) primary TURBTs were enrolled into the study Surgeons were divided into four groups based on their professional experiences: JR (Junior Residents)-residents of urology in the first three years of their training, SR (Senior Residents)-residents of urology in the second three years of their training, JS (Junior Specialists)-certified urologists up to 10 years after finishing the residency program, SS (Senior Specialists)-certified urologists for more than 10 years.
Statistical analysis
Percentages were calculated by dividing the number of records by the number of all available records. Continuous variables were presented as means. To evaluate factors that can be associated with performing BP univariate and multivariate stepwise forward logistic regression analyzes were used and a 2-sided p-value <0.05 was considered statistically significant. Statistical analyses were performed using STATISTICA 12 (StatSoft, USA).
This was a retrospective non-interventional study, so the informed consent and the Ethical Board approval were waived according to institutional regulations.
Results
There were 407 men and 161 women in the study cohort, with the male to female ratio of 2.5. The age of the patients ranged widely from 36 to 93 years, with a median value of 69.6 years. Pathological staging revealed stage Ta in 332 (59.8%), stage T1 in 116 (20.9%) and MIBC in 107 patients (19.3%).
Only 265 patients (46.7%) underwent BP according to surgical reports. Patients with MIBC underwent BP 2.1 times more often than patients with stage Ta cancer and 1.6 times more often than those with stage T1 cancer. Also gender and experience of the surgeons were positive predictive factors of performing BP. Table 1 presents characteristics of the patients, tumors and surgeons in univariate and multivariate analysis for performing BP during TURBT. In multivariate analysis, independent predictors for performing BP were tumor size and stage, as well as gender, and experience of the surgeon.
Table 1.
Univariate and multivariate analysis for performing BP during TURBT
| Total | BP performed | % | Relative risk | p-value univariative | p-value multivariative | |
|---|---|---|---|---|---|---|
| Total | 568 | 265 | 46.7 | |||
|
| ||||||
| Patient sex | ||||||
| F | 161 | 73 | 45.3 | 1 | 0.27 | |
| M | 407 | 192 | 47.2 | 1.04 | ||
| Age | 69.6 | 68.4 | 0.03 | 0.2 | ||
|
| ||||||
| Stage | ||||||
| Ta | 332 | 120 | 36.1 | 1 | <0.001 | <0.001 |
| T1 | 116 | 57 | 49.1 | 1.36 | ||
| T2 | 107 | 82 | 76.6 | 2.12 | ||
|
| ||||||
| Grade | ||||||
| PUNLUMP | 11 | 4 | 36.4 | 1 | <0.001 | 0.09 |
| Low Grade | 370 | 139 | 37.6 | 1.03 | ||
| High Grade | 179 | 116 | 64.8 | 1.78 | ||
|
| ||||||
| Number of tumors | ||||||
| Single | 396 | 186 | 47.0 | 1 | 0.64 | |
| Multifocal | 154 | 68 | 47.2 | 1 | ||
|
| ||||||
| Tumor size | ||||||
| <3 cm | 228 | 76 | 33.3 | 1 | <0.001 | <0.001 |
| >3 cm | 274 | 165 | 60.2 | 1.81 | ||
|
| ||||||
| Surgeon’s gender | ||||||
| F | 115 | 44 | 38.3 | 1 | 0.01 | 0.002 |
| M | 453 | 221 | 48.8 | 1.27 | ||
|
| ||||||
| Surgical experience | ||||||
| JR | 79 | 31 | 39.2 | 1.26 | 0.03 | 0.004 |
| SR | 158 | 102 | 64.6 | 2.08 | ||
| JS | 170 | 82 | 48.2 | 1.55 | ||
| SS | 161 | 50 | 31.1 | 1 | ||
BP: bimanual palpation; F: female; M: male; PUNLUMP: papillary urothelial neoplasm of low malignant potential; JR: junior resident; SR: senior resident; JS: junior specialist; SS: senior specialist
Clinical interpretations of 254 out of 265 patients who underwent BP were available. The patients had an impalpable tumor (n=183: 72%), a palpable and mobile mass (n=46: 18.1%), and an immobile mass (n=25: 9.8%). Detailed results of pathological examination regarding BPs are shown in Table 2.
Table 2.
Results of pathological examination in patients who underwent BP
| Result of pathological examination | All | % | Impalpable mass | % | Palpable mass, mobile bladder | % | Immobile bladder | % |
|---|---|---|---|---|---|---|---|---|
| Total | 254 | 183 | 46 | 25 | ||||
| Tx | 5 | 2.0 | 5 | 2.7 | 0 | 0 | 0 | 0 |
| Ta | 115 | 45.3 | 104 | 56.8 | 8 | 17.4 | 3 | 12.0 |
| T1 | 56 | 22.0 | 42 | 23.0 | 10 | 21.7 | 4 | 16.0 |
| MIBC | 77 | 30.3 | 32 | 17.5 | 28 | 58.3 | 17 | 68.0 |
Discussion
Accurate staging plays an indispensable role in the decision-making and management in patients with bladder cancer. We performed a retrospective analysis of BP performance in patients with bladder cancer, finding, that BP was often omitted, especially in cases of small, low stage tumors.
Study by Gray et al.[8] showed that early and accurate clinical staging decreases 5-year mortality rates in patients treated with radical cystectomy. Many authors have proven that diagnostic imaging such as CT, MRI or ultrasound may be efficient and accurate in clinical staging of bladder cancer.[9,10] However, clinical staging includes also BP which remains basic, but an important staging tool.[3,4,11] Our study shows that more than half of the patients with primary bladder cancer do not undergo BP during TURBT, despite the clinical guideline statements. Kellett et al.[6] first noticed in 1980 that CT may be as good as BP. It seems that it is more and more common to rely only on radiographic findings rather than physical examination which may be related to poor sensitivity (43–46%) and moderate specificity (75–82%) of BP.[3,5] However, Rozanski et al.[5] proved that performing BP independently improves staging accuracy, while combined with radiographic imaging it improves its specificity, positive and negative predictive values. Moreover, study by Wijkström et al.[12] showed that BP findings have a significant prognostic value for patient survival and thus are crucially important in clinical staging. On the other hand our study corresponds with other available data[3,4,13] showing lack of satisfactory concordance between results of BP with pathological results.
We also noticed that the percentage of patients who undergo BP differs significantly in certain subgroups. Firstly, stage of bladder cancer influenced the rate of performing BP. It was performed in as many as 76.6% of MIBC patients and only 39.5% of NMIBC patients. In a historical cohort, Ploeg et al.[13] noticed that 52.4% of their MIBC patients underwent BP, which was significantly lower relative to our cohort. This discrepancy may be partially explained by the fact that our department is a university teaching hospital, while Ploeg et al.[13] reported that BP is performed much more often in teaching than in non-teaching hospitals (62 vs. 30%). Grzegrzółkowski et al.[14] observed high accuracy of endoscopic visual staging in MIBC patients which explains why patients with MIBC undergo BP significantly more often than those with NMIBC. Moreover, in multivariate logistic regression analysis, we revealed that stage of the disease is an independent predictive factor for BP.
Second, we noticed that surgeon’s experience impacts the frequency of performing BP. Many authors suggest that surgeon-related factors (especially professional experience) influence the recurrence risk after TURBT.[15,16] In our study, senior residents did perform BP much more frequently than both junior residents and certified urologists. De Vries et al.[17] observed that senior residents show higher degree of completeness of the TURBT procedure with lower incidence of unintended events as compared to junior residents. However, surgical complications are more common with senior than junior residents.[18] Finally, when interpreting the phenomenon of higher BP rates among senior residents than certified urologists, one should remember that the overall quality of TURBT may be higher when performed by certified urologists.[19] We also observed that male urologists significantly more often perform BP than female urologists. The underlying cause is difficult to identify, however, the fact that female urologists may have less experience overall and less experience in oncological procedures in male patients could be of importance.[20,21]
Though the aim of the study was not to assess the accuracy of BP it seems to be important to notice that even among patients with NMIBC, some cases had palpable tumor and immobile bladder as detected with BP. This fact however does not prove, that BP should not be performed, because, as it was discussed before, performing BP improves staging accuracy.[5]
Main limitation of our study is its local character of analysis which may show some department-specific observations, especially as it is a tertiary center and a university hospital. The number of patients with MIBC, which are of the greatest importance in the context of BP, was limited. We have not analyzed available pathological data of cases who underwent radical cystectomy, thus value of BP was not evaluated. However, such studies have been previously performed and their results are available in the literature.[4,13] It is also a retrospective analysis which is based on medical documentation, so incomplete medical files may be a source of bias.
In conclusion, only minority of patients with primary bladder tumors submitted to TURBT undergo BP. Tumors of >3 cm, MIBC, senior resident surgeon and male surgeon are independent predictive factors for BP. Though it has been proved that bimanual palpation is beneficial for accurate tumor staging in patients with bladder cancer, it is very often omitted during TURBT.
Footnotes
Ethics Committee Approval: According to local regulations, the Review Board approval was waived for this retrospective non-interventional analysis.
Informed Consent: Due to the retrospective design of the study, informed consent was not taken.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept - S.P., B.D., P.R.; Design - L.B., S.P., B.D., P.R.; Supervision - S.P., B.D., P.R.; Resources - P.R.; Materials - L.B., P.M., M.O., J.S.; Data Collection and/or Processing - L.B., P.M., M.O., J.S.; Analysis and/or Interpretation - L.B., S.P.; Literature Search - L.B., S.P., B.D., P.R.; Writing Manuscript - L.B., S.P., B.D.; Critical Review - L.B., S.P., P.M., M.O., J.S., B.D., P.R.
Conflict of Interest: The authors have no conflicts of interest to declare.
Financial Disclosure: The authors declared that they haven’t received any financial support for this study.
References
- 1.Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2017;71:96–108. doi: 10.1016/j.eururo.2016.06.010. [DOI] [PubMed] [Google Scholar]
- 2.Poletajew S, Biernacki R, Buraczynski P, Chojnacki J, Czarniecki S, Gajewska D, et al. Stage of bladder cancer in Central Europe-Polish perspective. Neoplasma. 2016;63:642–7. doi: 10.4149/neo_2016_420. [DOI] [PubMed] [Google Scholar]
- 3.Mehrsai A, Mansoori D, Taheri Mahmoodi M, Sina A, Seraji A, Pourmand GH. A Comparison between clinical and pathologic staging in patients with bladder cancer. Urol J. 2004;1:85–9. [PubMed] [Google Scholar]
- 4.Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol. 2007;51:137–49. doi: 10.1016/j.eururo.2006.05.021. [DOI] [PubMed] [Google Scholar]
- 5.Rozanski AT, Benson CR, McCoy JA, Green C, Grossman HB, Svatek RS, et al. Is exam under anesthesia still necessary for the staging of bladder cancer in the era of modern imaging? Bladder Cancer. 2015;1:91–6. doi: 10.3233/BLC-150006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kellett MJ, Oliver RT, Husband JE, Fry IK. Computed tomography as an adjunct to bimanual examination for staging bladder tumours. Br J Urol. 1980;52:101–6. doi: 10.1111/j.1464-410X.1980.tb02938.x. [DOI] [PubMed] [Google Scholar]
- 7.Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU Guidelines on non-muscle invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol. 2017;71:447–61. doi: 10.1016/j.eururo.2016.05.041. [DOI] [PubMed] [Google Scholar]
- 8.Gray PJ, Lin CC, Jemal A, Shipley WU, Fedewa SA, Kibel AS, et al. Discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base. Int J Radiat Oncol Biol Phys. 2014;88:1048–56. doi: 10.1016/j.ijrobp.2014.01.001. [DOI] [PubMed] [Google Scholar]
- 9.Stojovska-Jovanovska E, Mitreska N, Stojovski M, Lazarova A, Stavridis S, Dodevski A. Computed tomography or magnetic resonance imaging-our experiences in determining preoperative TNM staging of bladder cancer. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2013;34:63–70. [PubMed] [Google Scholar]
- 10.Tadin T, Sotosek S, Rahelić D, Fuckar Z. Diagnostic accuracy of ultrasound T-staging of the urinary bladder cancer in comparison with histology in elderly patients. Coll Antropol. 2014;38:1123–6. [PubMed] [Google Scholar]
- 11.McLaughlin S, Shephard J, Wallen E, Maygarden S, Carson CC, Pruthi RS. Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer. Int Braz J Urol. 2007;33:25–31. doi: 10.1590/S1677-55382007000100005. [DOI] [PubMed] [Google Scholar]
- 12.Wijkström H, Norming U, Lagerkvist M, Nilsson B, Näslund I, Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol. 1998;81:686–91. doi: 10.1046/j.1464-410x.1998.00637.x. [DOI] [PubMed] [Google Scholar]
- 13.Ploeg M, Lambertus ALM, Kiemeney PD, Vergunst H, Viddeleer AC, Geboers AD, et al. Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy. Urol Oncol Semin Ori. 2012;30:247–51. doi: 10.1016/j.urolonc.2009.12.020. [DOI] [PubMed] [Google Scholar]
- 14.Grzegrzółkowski P, Kaczmarek K, Lemiński A, Soczawa M, Gołąb A, Słojewski M. Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study. Cent European J Urol. 2017;70:22–6. doi: 10.5173/ceju.2017.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jancke G, Rosell J, Jahnson S. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumor in non-muscle invasive bladder cancer. Scand J Urol. 2014;48:276–83. doi: 10.3109/21681805.2013.864327. [DOI] [PubMed] [Google Scholar]
- 16.Rolevich AI, Minich AA, Nabebina TI, Polyakov SL, Krasny SA, Sukonko OG. Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer. Cent European J Urol. 2016;69:170–7. doi: 10.5173/ceju.2016.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.de Vries AH, Boute MC, Kuppen MC, van Merriënboer JJ, Koldewijn EL, Pelger RC, et al. Patient Safety Risks of Basic Urological Procedures Performed by Junior and Senior Residents. J Surg Educ. 2015;72:918–26. doi: 10.1016/j.jsurg.2015.04.014. [DOI] [PubMed] [Google Scholar]
- 18.Nieder AM, Meinbach DS, Kim SS, Soloway MS. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol. 2005;174:2307–9. doi: 10.1097/01.ju.0000181797.19395.03. [DOI] [PubMed] [Google Scholar]
- 19.Bos D, Allard CB, Dason S, Ruzhynsky V, Kapoor A, Shayegan B. Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes. Scand J Urol. 2016;50:234–8. doi: 10.3109/21681805.2016.1163616. [DOI] [PubMed] [Google Scholar]
- 20.Spencer ES, Deal AM, Pruthi NR, Gonzalez CM, Kirby EW, Langston J, et al. Gender differences in compensation, job satisfaction and other practice patterns in urology. J Urol. 2016;195:450–5. doi: 10.1016/j.juro.2015.08.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Oberlin DT, Vo AX, Bachrach L, Flury SC. The impact of surgeon gender on surgical practice patterns in urology. J Urol. 2016;196:1522–6. doi: 10.1016/j.juro.2016.05.030. [DOI] [PubMed] [Google Scholar]
